Contract 75A50120C00177
Vedanta Biosciences, Inc. · Department Of Health And Human Services · September 25, 2020
Vedanta Biosciences, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 25, 2020 for $41.15 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Boston, MA. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses cost sharing contract pricing. The most recent modification was on December 3, 2025. If all options are exercised, the contract could reach $114.15 million.
Contract details
- PIID
- 75A50120C00177
- Award type
- Definitive Contract
- Pricing
- Cost Sharing
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- R&D- Other Research And Development (Advanced Development)
- Place of performance
- Boston, MA
- First action
- September 25, 2020
- Latest action
- December 3, 2025
Description
EO14042 TO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.
Modification timeline
-
December 3, 2025Mod P00015 · Supplemental Agreement For Work Within Scope$79.15M
-
September 23, 2025Mod P00014 · Other Administrative Action$79.15M
-
July 17, 2024Mod P00011 · Supplemental Agreement For Work Within Scope$61.15M
-
September 30, 2021Mod P00003 · Exercise An OptionTO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.$51.15M
-
September 25, 2020Base awardTO DEVELOP MEDICAL COUNTERMEASURES (MCMS) THAT TREAT ANTIBIOTIC RESISTANT INFECTIONS.$51.15M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50120C00177?
Contract 75A50120C00177 is a federal contract awarded to Vedanta Biosciences, Inc. by Department Of Health And Human Services on September 25, 2020 for $41.15 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 4 times since the base award.
Who won contract 75A50120C00177?
Vedanta Biosciences, Inc. won contract 75A50120C00177 from Department Of Health And Human Services.
How much is contract 75A50120C00177 worth?
Contract 75A50120C00177 has obligated $41.15 million to date, with a total potential value of $114.15 million if all options are exercised.